CEACAM5 and neoplasm: In fact, both CEACAM1 and CEACAM5 expressed on melanoma or 721.221 cells suppress NK cell-mediated cytotoxicity against tumor cells by interacting with and activating NK CEACAM1, which is a MHC I-independent inhibitory receptor [17], [18].